Dr. Chan is Editor of the Journal but did not participate in the peer review process other than as an author. The authors declare no other conflict of interest.
Clinical Practice Review
Nutritional management of acute pancreatitis in dogs and cats
Article first published online: 1 APR 2014
© Veterinary Emergency and Critical Care Society 2014
Journal of Veterinary Emergency and Critical Care
Volume 24, Issue 3, pages 240–250, May/June 2014
How to Cite
Jensen, K. B. and Chan, D. L. (2014), Nutritional management of acute pancreatitis in dogs and cats. Journal of Veterinary Emergency and Critical Care, 24: 240–250. doi: 10.1111/vec.12180
Dr. Jensen's current address is Djursjukhuset Malmö, Cypressvägen 11, 213 53 Malmö, Sweden.
- Issue published online: 24 JUN 2014
- Article first published online: 1 APR 2014
- Manuscript Accepted: 17 FEB 2014
- Manuscript Received: 16 AUG 2013
- enteral nutrition;
- pancreatic inflammation;
- parenteral nutrition
To review current and emerging nutritional approaches in the management of acute pancreatitis (AP) in people, dogs, and cats, and to provide a framework for further investigation in this field.
Veterinary retrospective studies and reviews, human prospective clinical trials and reviews, and experimental animal studies focusing on nutritional management during AP.
Nutritional management is an important part of the treatment plan for patients with AP. In human medicine, the general approach for providing nutrition in patients with AP has changed in recent years and favors enteral over parenteral nutrition with an emphasis on early enteral nutrition (EN). Although there are limited data available, there is increasing evidence in the veterinary literature that supports the beneficial role of EN in AP and contradicts previous assumptions about poor tolerance to enteral feeding in this patient population. Parenteral nutrition may be appropriate alone or in combination with EN as a temporary measure in malnourished patients that do not tolerate adequate EN; however, enteral feeding should be attempted first in most cases. Immunonutrition is being investigated for its positive role in modulating pancreatic inflammation and improving gut barrier function in cases of human AP.
The nutritional management of veterinary patients with AP remains challenging. Based on clinical evidence in people, experimental animal studies, and preliminary studies in dogs and cats, the choice of EN over parenteral nutritional support during AP in dogs and cats appears to be beneficial and well tolerated. Optimization of nutritional therapies in dogs and cats including the use of immunonutrition during AP warrants further investigation.